Skip to main content
Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc. — Investor Relations & Filings

Ticker · PRAX ISIN · US74006W2070 US Manufacturing
Open in API
Filings indexed 458 across all filing types
Latest filing 2022-02-28 Regulatory Filings
Country US United States of America
Listing US PRAX

About Praxis Precision Medicines, Inc.

https://praxismedicines.com/

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company that develops therapies for central nervous system (CNS) disorders. The company's methodology involves translating insights from genetic epilepsies into treatments for conditions characterized by neuronal excitation-inhibition imbalance. Praxis employs a genetics-focused approach, utilizing translational tools and patient-guided development strategies to advance its portfolio. The developmental pipeline includes several clinical-stage assets and numerous early-stage programs designed to address complex brain disorders.

Recent filings

Filing Released Lang Actions
FORM S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock option and employee stock purchase plans. It includes details about the stock plans, incorporation by reference of prior filings, exhibits related to stock option agreements, and signatures of company officers. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration for employee compensation plans. Therefore, it fits the category of Regulatory Filings (RNS). The document length is over 10,000 characters and contains detailed legal and regulatory content, confirming it is not a brief announcement or certification but a full registration statement.
2022-02-28 English
10-K
Annual Report FY 2021
2022-02-28 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated February 28, 2022, by Praxis Precision Medicines, Inc. It announces the company's financial results for the quarter and full year ended December 31, 2021, and includes a press release and a corporate presentation as exhibits. The text explicitly states that the press release and presentation are furnished as exhibits and that the information is intended to be furnished, not filed, indicating this is an announcement of results rather than the full earnings report itself. The document is relatively short (4072 characters) and serves as a regulatory filing to announce the earnings release and investor presentation. Therefore, it fits best under Regulatory Filings (RNS) as a general announcement and furnishing of materials, not the earnings release (ER) itself or the investor presentation (IP) report.
2022-02-28 English
FORM 4
Director's Dealing
2022-02-16 English
FORM 4
Director's Dealing
2022-02-16 English
FORM 4
Director's Dealing
2022-02-16 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.